SynthesisBMC pulmonary medicine2014

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC).

Ansgar Lange et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.